Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.15 -0.09 (-2.12%)
At close: Nov 10, 2026 · 4:00 PM EST

Aclaris Therapeutics (ACRS) Other Operating Expenses (2016 - 2026)

Updated

Aclaris Therapeutics (ACRS) posted Other Operating Expenses of $19.82 million for Q2 2026, up 33.9% from $14.8 million a year earlier and up 13.6% from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Other Operating Expenses (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other Operating Expenses at Aclaris Therapeutics was $71.29 million, down 49.5% year-over-year; for FY2025, it came in at $62.23 million, down 55.1% from FY2024.

  • Annual Other Operating Expenses shows a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
  • In prior years, Aclaris Therapeutics' Other Operating Expenses was $138.45 million in FY2024 (+54.6%), $89.57 million in FY2023 (-5.2%), $94.47 million in FY2022 (+29.7%) and $72.87 million in FY2021 (+97.7%).
  • The Q2 2026 figure stands as the highest quarterly Other Operating Expenses since Q4 2024.
  • On a year-over-year basis, Other Operating Expenses increased in five of the last eight quarters, with growth averaging 85.4%.
  • The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q4 2024, with growth of 675.4%; the weakest was Q4 2025, with a decline of 82.2%.
  • According to Business Quant data, Other Operating Expenses for the three prior quarters was $17.45 million (Q1 2026), $18.45 million (Q4 2025) and $15.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Aclaris Therapeutics 625.92 Mn 223.91 Mn 1.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -600,000.00
Jun 30, 2026 300,000.00
Dec 31, 2025 400,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 1.50 Mn
Mar 31, 2025 300,000.00
Dec 31, 2024 -1.30 Mn
Sep 30, 2024 800,000.00
Jun 30, 2024 200,000.00
Mar 31, 2024 2.80 Mn
Dec 31, 2023 -26.30 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 -1.50 Mn
Mar 31, 2023 -800,000.00
Dec 31, 2022 7.10 Mn
Sep 30, 2022 2.20 Mn
Jun 30, 2022 -3.40 Mn
Mar 31, 2022 -1.20 Mn
Dec 31, 2021 2.20 Mn
Sep 30, 2021 900,000.00
API Access

Aclaris Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ACRS&period=max&api_key=YOUR_API_KEY